| GB8610572D0 (en) | | Pharmaceutical preparation |
| GB8717643D0 (en) | | Oral therapeutic system |
| ZA868249B (en) | | Pharmaceutical preparation |
| GB8618847D0 (en) | | Pharmaceutical formulations |
| ZA875813B (en) | | Pharmaceutical compounds |
| CS8700282A2 (en) | | Nicorandil-containing stable pharmaceutical |
| GB8607817D0 (en) | | Drug preparation |
| GB8500310D0 (en) | | Pharmaceutical preparation |
| ZA877699B (en) | | Pharmaceutical combination |
| GB8721313D0 (en) | | Pharmaceutical preparation |
| GB8625326D0 (en) | | Medicaments |
| GB8610815D0 (en) | | Oral anti-malarial medicines |
| GB8725175D0 (en) | | Oral anti-malarial medicines |
| BG43202A1 (en) | | Solid oral therapeutic form containing silimarin |
| GR871915B (en) | | Pharmaceutical formulations |
| GB8701281D0 (en) | | Pharmaceutical solution |
| IE861385L (en) | | Oral pharmaceutical composition |
| GB8620463D0 (en) | | Pharmaceutical |
| BG43026A1 (en) | | Lyposomic pharmaceutical form |
| ZA87111B (en) | | Pharmaceutical dosage form |
| GB8626199D0 (en) | | Pharmaceutical compounds |
| GB8605037D0 (en) | | Oral pharmaceutical compositions |
| GB8522761D0 (en) | | Pharmaceutical preparation |
| GB8603097D0 (en) | | Pharmaceutical formulations |
| ZA876959B (en) | | Pharmaceutical formulations |